Where I see patients (1)
My reviews
Selected research
Clinical trials
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meni...
Percentage of patients who are progression-free at the landmark of 12 months from start of treatment based on the target lesion(s) that are receiving radiation treatment will be reported. Tumor progression will be assessed using I...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-7500
4.9